{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibcyhng4elcu6qvzlehkfl2422wyjdfbr2bcmuxnmsxuekiqqxcpe",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgvufmns5aw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibodeetd3skhxfcdw6muphkka5zholqcd7d2dqw7hszra7kneq6de"
    },
    "mimeType": "image/jpeg",
    "size": 650447
  },
  "path": "/news/2026-03-trial-immunotherapy-survival-added-chemoradiotherapy.html",
  "publishedAt": "2026-03-12T22:20:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the Journal of Clinical Oncology.",
  "title": "Trial finds immunotherapy did not improve survival when added to chemoradiotherapy for small cell lung cancer"
}